Chang Han

3.7k citations

61 papers · 2.5k indexed · h-index 28

Impact in

Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology

Papers in

Hepatology 9
- Liver physiology and pathology 8
Cancer Research 15
- Cancer, Lipids, and Metabolism 7

Co-authors: Tong Wu Jing Leng Kyu Lim George K. Michalopoulos Anthony J. Demetris Jake Demetris James H. Shelhamer Lihong Xu
Journals: Hepatology (7 papers)Cancer Research (6 papers)The FASEB Journal (5 papers)Journal of Biological Chemistry (3 papers)Molecular Cancer Therapeutics (3 papers)
Partner nations: United States China South Korea

In The Last Decade

Chang Han

60 papers receiving 2.4k citations

Peers

Countries citing papers authored by Chang Han

Since Specialization

Citations

This map shows the geographic impact of Chang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Han more than expected).

Fields of papers citing papers by Chang Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Han. The network helps show where Chang Han may publish in the future.

Co-authors

The 25 scholars most cited alongside Chang Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chang Han Line = papers co-authored together Chang Han links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An integrative analysis to predict the active compounds and explore polypharmacological mechanisms of Orthosiphon stamineus Benth. Computers in Biology and Medicine ·Xingqiang Wang, Weiqing Zhao, A Álvaro Echeverri, Zongqing Wang, Chang Han, Aniqua Tahir, Fengyan Qiu, Hyeongju Park, Zhaofu Li	2023	5
2	Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer Cancers ·Chia‐Huei Lee, Ji-Rui Yang, Chih‐Yu Chen, Ming‐Hsien Tsai, نعمات محمد سعيد بشارة, Loránt Tilkovszky, Shang‐Lun Chiang, Chang Han, Pinpin Lin	2019	20
3	First report of Enterocytozoon bieneusi and Cryptosporidium spp. in peafowl (Pavo cristatus) in China International Journal for Parasitology Parasites and Wildlife ·Xiao Mei Yin, Chang Han, Jing Luo, Михайлев А. В. Капустина О. А., Hongxuan He	2019	14
4	Update on FXR Biology: Promising Therapeutic Target? International Journal of Molecular Sciences ·Chang Han	2018	146
5	IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines Molecular Cancer Therapeutics ·Fei Huang, Chang Han, Ann Greer, Stephen Hillerman, Karen A. Reeves, Warren Hurlburt, John Cogswell, Ana Tolić, Zhenhao Qi, Craig Fairchild, Rolf-Peter Ryseck, Tai W. Wong, Friedrich Graf Finckenstein, Jeffrey R. Jackson, Joan M. Carboni	2014	25
6	miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth Molecular Cancer Research ·Houria Laoufi, Kathleen Byrnes, Chang Han, Ying Wang, Tong Wu	2014	49
7	Involvement of MyD88 in zinc oxide nanoparticle-induced lung inflammation Experimental and Toxicologic Pathology ·Chang Han, Chia‐Chi Ho, Chung Shi Yang, Wan‐Hsuan Chang, Ming‐Hsien Tsai, Hui-Ti Tsai, Pinpin Lin	2013	45
8	Hedgehog Signaling Pathway Regulates Autophagy in Human Hepatocellular Carcinoma Cells Hepatology ·Ying Wang, Chang Han, Houria Laoufi, Jundi Yang, Tong Wu	2013	136
9	Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung Nanotoxicology ·Chia‐Chi Ho, Chang Han, Hui-Ti Tsai, Ming‐Hsien Tsai, Chung‐Shi Yang, Yong‐Chien Ling, Pinpin Lin	2011	56
10	Cytosolic phospholipase A2α protects against Fas- but not LPS-induced liver injury Journal of Hepatology ·Guiying Li, Weina Chen, Chang Han, Tong Wu	2011	9
11	Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53 Autophagy ·Kaipeng Jing, Kyoungsub Song, Soyeon Shin, Nayeong Kim, Soyeon Jeong, Shih-Yi Hsu, Ji-Hoon Park, Kang-Sik Seo, Jun Young Heo, Jeongsu Han, Jong‐Il Park, Chang Han, Tong Wu, Gi‐Ryang Kweon, Seung‐Kiel Park, Woong Yoon, Byung‐Doo Hwang, Kyu Lim	2011	170
12	Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression Gastroenterology ·Dongdong Lu, Chang Han, Tong Wu	2011	23
13	Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model Cancer Research ·Fei Huang, Warren Hurlburt, Ann Greer, Karen A. Reeves, Stephen Hillerman, Chang Han, Joseph Fargnoli, Friedrich Graf Finckenstein, Marco M. Gottardis, Joan M. Carboni	2010	97
14	Cytosolic phospholipase A2α and peroxisome proliferator‐activated receptor γ signaling pathway counteracts transforming growth factor β–mediated inhibition of primary and transformed hepatocyte growth† Hepatology ·Chang Han, William C. Bowen, Guiying Li, Anthony J. Demetris, George K. Michalopoulos, Tong Wu	2010	30
15	Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2 Molecular Cancer Therapeutics ·Kyu Lim, Chang Han, Yifan Dai, Miaoda Shen, Tong Wu	2009	153
16	Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor # Hepatology ·Guiying Li, Chang Han, Lihong Xu, Kyu Lim, Kumiko Isse, Tong Wu	2009	20
17	Cyclooxygenase-2–Derived Prostaglandin E2 Activates β-Catenin in Human Cholangiocarcinoma Cells: Evidence for Inhibition of These Signaling Pathways by ω3 Polyunsaturated Fatty Acids Cancer Research ·Kyu Lim, Chang Han, Lihong Xu, Kumiko Isse, Anthony J. Demetris, Tong Wu	2008	83
18	Docosahexaenoic acid-induced apoptotic cell death is correlated with inhibition of β-catenin/wnt signaling pathway and Cox-2 in human pancreatic cancer cells Cancer Research ·Kyoungsub Song, Eun-Jin Yun, Jong-Seok Kim, Jun Young Heo, Yeonjoo Jung, Chang Han, Tong Wu, Jong‐Il Park, Gi‐Ryang Kweon, Seung‐Kiel Park, Woong Yoon, Byung‐Doo Hwang, Kyu Lim	2008	0
19	Pparγ Ligands Inhibit Cholangiocarcinoma Cell Growth Through P53–Dependent Gadd45 and P21Waf1/Cip1 Pathway Hepatology ·Chang Han, Jake Demetris, George K. Michalopoulos, Qimin Zhan, James H. Shelhamer, Tong Wu	2003	58
20	Involvement of 85-kd cytosolic phospholipase A2 and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells Hepatology ·Tong Wu, Chang Han, John G. Lunz, George K. Michalopoulos, James H. Shelhamer, Jake Demetris	2002	56

About Chang Han

Chang Han is a scholar working on Hepatology, Cancer Research, Pharmacology, Biochemistry and Pharmacology, having authored 61 papers that have together received 2.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Liver physiology and pathology (8 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Cancer, Lipids, and Metabolism (7 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Hedgehog Signaling Pathway Studies (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Cancer Research (519 citations), Biochemistry (205 citations), Pharmacology (434 citations), Hepatology (203 citations) and Oncology (469 citations). Chang Han has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Tong Wu, Tong Wu, Jing Leng, Kyu Lim, George K. Michalopoulos, Anthony J. Demetris, Jake Demetris, Tong Wu, James H. Shelhamer and Lihong Xu. Their work appears in journals such as Hepatology, Cancer Research, The FASEB Journal, Journal of Biological Chemistry and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact